cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lexicon Pharmaceuticals Inc
38 own
31 watching
Current Price
$2.62
$0.18
(7.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
298.81M
52-Week High
52-Week High
3.79000
52-Week Low
52-Week Low
0.92000
Average Volume
Average Volume
5.84M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
8.9838
iconMarket Capitalization298.81M
icon52-Week High3.79000
icon52-Week Low0.92000
iconAverage Volume5.84M
iconDividend Yield--
iconP/E Ratio8.9838
What does the Lexicon Pharmaceuticals Inc do?
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of human diseases. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with SSA therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that is in Phase 3 clinical trials for use in the treatment of type 1 and type 2 diabetes; LX2761, which is in Phase 1 development for use in the treatment of diabetes; and LX9211 for use as a treatment for neuropathic pain. The company has license and collaboration agreements with Sanofi; Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.
Read More
How much money does Lexicon Pharmaceuticals Inc make?
News & Events about Lexicon Pharmaceuticals Inc.
Globe Newswire
8 months ago
First late-stage study will be a Phase 2b dose optimization study, with extension to run in parallel with next-stage Phase 3 studies Feedback obtained from U.S. Food and Drug Administration (FDA) Conference Call and Webcast on Monday, June 26, 2023, at 8:00 am Eastern Time THE WOODLANDS, Texas, June...
Globe Newswire
10 months ago
Data accepted as AAN Late-Breaking AbstractTHE WOODLANDS Texas, April 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that results from RELIEF-PHN-1, a Phase 2 double-blind, placebo-controlled trial of its investigational drug LX9211 for the treatment of ...
Ticker Report
10 months ago
StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) to a sell rating in a research report released on Saturday. Separately, Jefferies Financial Group started coverage on shares of Lexicon Pharmaceuticals in a research note on Tuesday, March 7th. They set a hold ...
Globe Newswire
12 months ago
Statistically significant reduction in the risk for the primary outcome on Day 27 Findings generally consistent across the left ventricular ejection fraction (LVEF) range THE WOODLANDS, Texas, March 04, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced new ...
Globe Newswire
12 months ago
Into the Dark Into the Dark Campaign Image Emphasizes challenges faced by patients and clinicians within the first 30 days after discharge from a heart failure hospitalization Reinforces impact of rehospitalizations for heart failure patients and healthcare system Campaign launches at American ...
Frequently Asked Questions
Frequently Asked Questions
What is Lexicon Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Lexicon Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Lexicon Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Lexicon Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Lexicon Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Lexicon Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Lexicon Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Lexicon Pharmaceuticals Inc?
plus_minus_icon
What percentage is Lexicon Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Lexicon Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.62
$0.18
(7.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00